These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20623110)

  • 1. Cognitive function is related to fronto-striatal serotonin transporter levels--a brain PET study in young healthy subjects.
    Madsen K; Erritzoe D; Mortensen EL; Gade A; Madsen J; Baaré W; Knudsen GM; Hasselbalch SG
    Psychopharmacology (Berl); 2011 Feb; 213(2-3):573-81. PubMed ID: 20623110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+/-)3,4-methylenedioxymethamphetamine ("ecstasy") users: relationship to cognitive performance.
    McCann UD; Szabo Z; Vranesic M; Palermo M; Mathews WB; Ravert HT; Dannals RF; Ricaurte GA
    Psychopharmacology (Berl); 2008 Oct; 200(3):439-50. PubMed ID: 18661256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered interregional molecular associations of the serotonin transporter in attention deficit/hyperactivity disorder assessed with PET.
    Vanicek T; Kutzelnigg A; Philippe C; Sigurdardottir HL; James GM; Hahn A; Kranz GS; Höflich A; Kautzky A; Traub-Weidinger T; Hacker M; Wadsak W; Mitterhauser M; Kasper S; Lanzenberger R
    Hum Brain Mapp; 2017 Feb; 38(2):792-802. PubMed ID: 27770470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal and prefrontal D2R and SERT distributions contrastingly correlate with default-mode connectivity.
    Ionescu TM; Amend M; Hafiz R; Biswal BB; Maurer A; Pichler BJ; Wehrl HF; Herfert K
    Neuroimage; 2021 Nov; 243():118501. PubMed ID: 34428573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuated serotonin transporter association between dorsal raphe and ventral striatum in major depression.
    Hahn A; Haeusler D; Kraus C; Höflich AS; Kranz GS; Baldinger P; Savli M; Mitterhauser M; Wadsak W; Karanikas G; Kasper S; Lanzenberger R
    Hum Brain Mapp; 2014 Aug; 35(8):3857-66. PubMed ID: 24443158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nonlinear relationship between cerebral serotonin transporter and 5-HT(2A) receptor binding: an in vivo molecular imaging study in humans.
    Erritzoe D; Holst K; Frokjaer VG; Licht CL; Kalbitzer J; Nielsen FA; Svarer C; Madsen J; Knudsen G
    J Neurosci; 2010 Mar; 30(9):3391-7. PubMed ID: 20203198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple and rapid quantification of serotonin transporter binding using [
    Gryglewski G; Rischka L; Philippe C; Hahn A; James GM; Klebermass E; Hienert M; Silberbauer L; Vanicek T; Kautzky A; Berroterán-Infante N; Nics L; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Kasper S; Lanzenberger R
    Neuroimage; 2017 Apr; 149():23-32. PubMed ID: 28119137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High familial risk for mood disorder is associated with low dorsolateral prefrontal cortex serotonin transporter binding.
    Frokjaer VG; Vinberg M; Erritzoe D; Svarer C; Baaré W; Budtz-Joergensen E; Madsen K; Madsen J; Kessing LV; Knudsen GM
    Neuroimage; 2009 Jun; 46(2):360-6. PubMed ID: 19233297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disproportionate Reduction of Serotonin Transporter May Predict the Response and Adherence to Antidepressants in Patients with Major Depressive Disorder: A Positron Emission Tomography Study with 4-[18F]-ADAM.
    Yeh YW; Ho PS; Kuo SC; Chen CY; Liang CS; Yen CH; Huang CC; Ma KH; Shiue CY; Huang WS; Shyu JF; Wan FJ; Lu RB; Huang SY
    Int J Neuropsychopharmacol; 2015 Jan; 18(7):pyu120. PubMed ID: 25568284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preserved serotonin transporter binding in de novo Parkinson's disease: negative correlation with the dopamine transporter.
    Strecker K; Wegner F; Hesse S; Becker GA; Patt M; Meyer PM; Lobsien D; Schwarz J; Sabri O
    J Neurol; 2011 Jan; 258(1):19-26. PubMed ID: 20644949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre- and postsynaptic serotonergic differences in males with extreme levels of impulsive aggression without callous unemotional traits: a positron emission tomography study using (11)C-DASB and (11)C-MDL100907.
    Rylands AJ; Hinz R; Jones M; Holmes SE; Feldmann M; Brown G; McMahon AW; Talbot PS
    Biol Psychiatry; 2012 Dec; 72(12):1004-11. PubMed ID: 22835812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Processing speed is related to striatal dopamine transporter availability in Parkinson's disease.
    Vriend C; van Balkom TD; van Druningen C; Klein M; van der Werf YD; Berendse HW; van den Heuvel OA
    Neuroimage Clin; 2020; 26():102257. PubMed ID: 32344372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prefrontal serotonin transporter availability is positively associated with the cortisol awakening response.
    Frokjaer VG; Erritzoe D; Holst KK; Jensen PS; Rasmussen PM; Fisher PM; Baaré W; Madsen KS; Madsen J; Svarer C; Knudsen GM
    Eur Neuropsychopharmacol; 2013 Apr; 23(4):285-94. PubMed ID: 22732516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin transporter binding in the hypothalamus correlates negatively with tonic heat pain ratings in healthy subjects: a [11C]DASB PET study.
    Kupers R; Frokjaer VG; Erritzoe D; Naert A; Budtz-Joergensen E; Nielsen FA; Kehlet H; Knudsen GM
    Neuroimage; 2011 Jan; 54(2):1336-43. PubMed ID: 20851771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired cognition in bipolar I disorder: the roles of the serotonin transporter and brain-derived neurotrophic factor.
    Chou YH; Wang SJ; Lirng JF; Lin CL; Yang KC; Chen CK; Yeh CB; Liao MH
    J Affect Disord; 2012 Dec; 143(1-3):131-7. PubMed ID: 22889524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin transporter availability in thalamic subregions in schizophrenia: a study using 7.0-T MRI with [(11)C]DASB high-resolution PET.
    Kim JH; Son YD; Kim JH; Choi EJ; Lee SY; Lee JE; Cho ZH; Kim YB
    Psychiatry Res; 2015 Jan; 231(1):50-7. PubMed ID: 25465315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open-label positron emission tomography study to evaluate serotonin transporter occupancy following escalating dosing regimens of (R)-(-)-O-desmethylvenlafaxine and racemic O-desmethylvenlafaxine.
    Frankle WG; Robertson B; Maier G; Paris J; Asmonga D; May M; Himes ML; Mason NS; Mathis CA; Narendran R
    Synapse; 2018 Mar; 72(3):. PubMed ID: 29216407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonergic dysregulation is linked to sleep problems in Parkinson's disease.
    Wilson H; Giordano B; Turkheimer FE; Chaudhuri KR; Politis M
    Neuroimage Clin; 2018; 18():630-637. PubMed ID: 29845011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In abstinent MDMA users the cortisol awakening response is off-set but associated with prefrontal serotonin transporter binding as in non-users.
    Frokjaer VG; Erritzoe D; Holst KK; Madsen KS; Fisher PM; Madsen J; Svarer C; Knudsen GM
    Int J Neuropsychopharmacol; 2014 Aug; 17(8):1119-28. PubMed ID: 24524290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased brainstem and putamen SERT binding potential in depressed suicide attempters using [11C]-zient PET imaging.
    Nye JA; Purselle D; Plisson C; Voll RJ; Stehouwer JS; Votaw JR; Kilts CD; Goodman MM; Nemeroff CB
    Depress Anxiety; 2013 Oct; 30(10):902-7. PubMed ID: 23526784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.